It has been shown that smooth muscle cells undergo degeneration and atrophy during AD (Farkas and Luiten, 2001); therefore, the up-regulated α-SMA levels observed here might be an indicator of a systemic compensatory mechanism. The gene discussed is ACTA1; the disease is Alzheimer disease.